Hikma says considering strategic options for injectables business

March 1 Fri Mar 1, 2013 5:32am EST

Related Topics

March 1 (Reuters) - Hikma Pharmaceuticals Plc said it reviewing options for its injectables business.

"We have received a number of unsolicited expressions of interest in our injectables business and will consider the best option for shareholders," Chief Executive Said Darwazah said in a statement.

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.